Skip to main content
SpringerLink
Log in

Healthcare costs increase prior to and after MS diagnosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2019 euros

  2. people with MS

Reference

  • Murley C, et al. Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group PharmacoEconomics : 10 May 2021. Available from: URL: https://doi.org/10.1007/s40273-021-01035-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Healthcare costs increase prior to and after MS diagnosis. PharmacoEcon Outcomes News 879, 14 (2021). https://doi.org/10.1007/s40274-021-7737-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7737-5

Search

Navigation